Wave Life Sci Ord Sh (WVE) Stock Price, Quote & News

Company Profile

Wave Life Sciences Ltd., a clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform. The company's RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. It is developing WVE-006, an RNA editing oligonucleotide for the treatment of alpha-1 ant...

Industry: Biotechnology

Sector: Healthcare

Phone: 65 6236 3388

Website: wavelifesciences.com

Address:

Marina One East Tower, 7 Straits View No.12-00, Singapore, Singapore

dirkfrank Nov. 13 at 4:06 PM

$WVE

0 · Reply

SaluteYourShorts Nov. 11 at 4:02 PM

$WVE add some 7.25

0 · Reply

JarvisFlow Nov. 11 at 2:59 PM

Wedbush has updated their rating for WAVE Life Sciences ( $WVE ) to Outperform with a price target of 20.

0 · Reply

JarvisFlow Nov. 11 at 2:35 PM

Wells Fargo updates rating for WAVE Life Sciences ( $WVE ) to Overweight, target set at 18 → 16.

0 · Reply

Longbuy1 Nov. 10 at 11:16 PM

$VERA $WVE Vera gonna be rocking again tomorrow

0 · Reply

MysticChartReaderIQ69 Nov. 10 at 6:15 PM

$WVE so raising before full obesity data readout is the problem here ?

1 · Reply

johnnygogogo Nov. 10 at 5:12 PM

$WVE Auntie Em confirmed. $72.1M subsequent to Sept. 30 @skeezbag

0 · Reply

outlawinvestor1 Nov. 10 at 2:21 PM

$WVE just started listening in. did they mention anything about weight loss inhbe data?

0 · Reply

SuperGreenToday Nov. 7 at 6:40 PM

$WVE Share Price: $7.69 Contract Selected: Apr 17, 2026 $10 Calls Buy Zone: $1.32 – $1.63 Target Zone: $2.24 – $2.73 Potential Upside: 60% ROI Time to Expiration: 160 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

dirkfrank Nov. 7 at 3:46 PM

$WVE see You in 2030

0 · Reply

These Analysts Revise Their Forecasts On Wave Life Sciences Following Q3 Results

Nov 10, 2025, 8:01 PM EST - 6 days ago

Wave Life Sciences Ltd. (WVE) Q3 2025 Earnings Call Transcript

Nov 10, 2025, 7:30 AM EST - 6 days ago

Wave Life Sciences Reports Third Quarter 2025 Financial Results and Provides Business Update

Nov 7, 2025, 8:30 AM EST - 9 days ago

Wave Life Sciences to Present at Upcoming Investor Conferences

Nov 4, 2025, 8:30 PM EST - 12 days ago

Wave Life Sciences to Present Preclinical Data Supporting Therapeutic Potential of WVE-007 for Obesity at ObesityWeek® 2025

Nov 4, 2025, 8:30 AM EST - 12 days ago

Wave Life Sciences Third Quarter 2025 Financial Results Scheduled for November 10, 2025

Nov 1, 2025, 3:06 AM EDT - 16 days ago

Wave Life Sciences Ltd. (WVE) Spotlight on RNA Editing and RNAi: Pipeline and Clinical Advances in Oligonucleotide Therapeutics Transcript

Oct 29, 2025, 10:50 PM EDT - 18 days ago

Correcting and Replacing Wave Life Sciences Announced Positive Target Engagement Data from INLIGHT Clinical Trial of WVE-007 for Obesity During Annual Research Day

Oct 29, 2025, 4:15 PM EDT - 18 days ago

Wave Life Sciences Announced Positive Target Engagement Data from INLIGHT Clinical Trial of WVE-007 for Obesity During Annual Research Day

Sep 18, 2025, 8:30 AM EDT - 2 months ago

Wave Life Sciences Announces Virtual Research Day on October 29th and Participation at Upcoming Investor Conferences

Sep 3, 2025, 3:10 PM EDT - 2 months ago

Wave Life Sciences Ltd. (WVE) Positive RestorAATion-2 Clinical Data Update Conference Transcript

Sep 3, 2025, 1:28 PM EDT - 2 months ago

Why Is GSK Partner Wave Life Sciences Stock Trading Lower On Wednesday?

GSK

Sep 3, 2025, 7:30 AM EDT - 2 months ago

Wave Life Sciences Announces Positive Update from Ongoing RestorAATion-2 Trial of WVE-006 in Alpha-1 Antitrypsin Deficiency

Jul 30, 2025, 9:38 PM EDT - 3 months ago

Wave Life Sciences Ltd. (WVE) Q2 2025 Earnings Call Transcript

Jul 30, 2025, 7:30 AM EDT - 3 months ago

Wave Life Sciences Reports Second Quarter 2025 Financial Results and Provides Business Update

Jul 23, 2025, 8:30 AM EDT - 4 months ago

Wave Life Sciences Second Quarter 2025 Financial Results Scheduled for July 30, 2025

Jul 7, 2025, 5:42 PM EDT - 4 months ago

Wave Life Sciences: Upgrading Rating To Buy After Turbulent 10 Months

Jun 20, 2025, 4:01 PM EDT - 5 months ago

Wave Life Sciences Announces Oral Presentation of Preclinical Data Supporting WVE-007's Mechanism (INHBE) to Reduce Fat, Preserve Muscle, and Induce Healthy Weight Loss at ADA's Annual Scientific Sessions

May 29, 2025, 8:30 AM EDT - 6 months ago

Wave Life Sciences to Present at 2025 Jefferies Global Healthcare Conference

May 28, 2025, 8:00 AM EDT - 6 months ago

Wave Life Sciences Announces Appointment of Dr. Christopher Wright as Chief Medical Officer

May 9, 2025, 4:57 PM EDT - 6 months ago

Wave Life Sciences Ltd. (WVE) Q1 2025 Earnings Call Transcript

May 8, 2025, 7:30 AM EDT - 6 months ago

Wave Life Sciences Reports First Quarter 2025 Financial Results and Provides Business Update

May 1, 2025, 8:30 AM EDT - 7 months ago

Wave Life Sciences First Quarter 2025 Financial Results Scheduled for May 8, 2025

Mar 27, 2025, 3:54 PM EDT - 8 months ago

Wave Life Sciences: Potential For Accelerated Approval Pathway With WVE-N531

Mar 26, 2025, 10:21 AM EDT - 8 months ago

Wave Life Sciences Stock Jumps On Positive Data From Muscle Disorder Drug, Plans FDA Submission Next Year

Mar 26, 2025, 7:30 AM EDT - 8 months ago

Wave Life Sciences Announces Positive Data from FORWARD-53 Clinical Trial in DMD Including Significant Functional Benefit and Reversal of Muscle Damage after 48 Weeks of Dosing with WVE-N531

Mar 4, 2025, 3:16 PM EST - 9 months ago

Wave Life Sciences Ltd. (WVE) Q4 2024 Earnings Call Transcript

Mar 4, 2025, 7:30 AM EST - 9 months ago

Wave Life Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Feb 25, 2025, 8:30 AM EST - 9 months ago

Wave Life Sciences Fourth Quarter and Full Year 2024 Financial Results Scheduled for March 4, 2025

Feb 6, 2025, 8:30 AM EST - 10 months ago

Wave Life Sciences Announces Initiation of Phase 1 INLIGHT Clinical Trial of WVE-007 in Obesity

Jan 8, 2025, 1:35 AM EST - 11 months ago

Wave Life Sciences Is A Buy On Pipeline Prospects

Dec 23, 2024, 8:30 AM EST - 11 months ago

Wave Life Sciences Announces Submission of First Clinical Trial Application for WVE-007 (siRNA Targeting INHBE) in Obesity

Dec 16, 2024, 8:30 AM EST - 11 months ago

Wave Life Sciences to Present at 43rd Annual J.P. Morgan Healthcare Conference

Nov 15, 2024, 8:30 AM EST - 1 year ago

Wave Life Sciences to Present at Jefferies London Healthcare Conference

Nov 12, 2024, 12:20 PM EST - 1 year ago

Wave Life Sciences Ltd. (WVE) Q3 2024 Earnings Call Transcript

Oct 30, 2024, 4:45 PM EDT - 1 year ago

Wave Life Sciences Highlights Growing Pipeline at Research Day, including INHBE siRNA Program for Obesity and New RNA Editing Programs

Oct 16, 2024, 4:43 PM EDT - 1 year ago

Wave Life Sciences: Positive WVE-006 Data For AATD Leads To 2025 Catalyst

Oct 16, 2024, 2:43 PM EDT - 1 year ago

This Cisco Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday

CSCO GWW SAP WLK

Oct 16, 2024, 11:19 AM EDT - 1 year ago

Wave Life Sciences Reveals RNA Editing Breakthrough, Reports First-Ever Clinical Proof-Of-Mechanism In Humans

Oct 16, 2024, 8:25 AM EDT - 1 year ago

Wave Life Sciences Announces Upcoming Virtual Research Day on Wednesday, October 30, 2024

Oct 1, 2024, 9:20 AM EDT - 1 year ago

Wave Life Sciences Announces Closing of Upsized Public Offering of Ordinary Shares and Pre-Funded Warrants and Full Exercise of Underwriters' Option to Purchase Additional Shares

Sep 30, 2024, 8:30 AM EDT - 1 year ago

Wave Life Sciences to Present at Chardan 8th Annual Genetic Medicines Conference

Sep 26, 2024, 12:05 PM EDT - 1 year ago

Analysts Predict 85% Upside for Wave Life Sciences After Rate Cut

Sep 25, 2024, 9:14 PM EDT - 1 year ago

Wave Life Sciences Prices Upsized $200 Million Public Offering of Ordinary Shares and Pre-Funded Warrants

Sep 24, 2024, 4:01 PM EDT - 1 year ago

Wave Life Sciences Announces Proposed Public Offering of Ordinary Shares and Pre-Funded Warrants

Sep 24, 2024, 1:41 PM EDT - 1 year ago

Wave Life Sciences' stock soars 51% after biotech posts positive data from Duchenne muscular-dystrophy trial

Sep 24, 2024, 7:30 AM EDT - 1 year ago

Wave Life Sciences Announces Positive Interim Data from FORWARD-53 Clinical Trial Evaluating WVE-N531 in Boys with Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping

Aug 10, 2024, 10:27 AM EDT - 1 year ago

Wave Life Sciences Ltd. (WVE) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 7:30 AM EDT - 1 year ago

Wave Life Sciences Reports Second Quarter 2024 Financial Results and Provides Business Update

Aug 1, 2024, 8:30 AM EDT - 1 year ago

Wave Life Sciences Second Quarter 2024 Financial Results Scheduled for August 8, 2024

dirkfrank Nov. 13 at 4:06 PM

$WVE

0 · Reply

SaluteYourShorts Nov. 11 at 4:02 PM

$WVE add some 7.25

0 · Reply

JarvisFlow Nov. 11 at 2:59 PM

Wedbush has updated their rating for WAVE Life Sciences ( $WVE ) to Outperform with a price target of 20.

0 · Reply

JarvisFlow Nov. 11 at 2:35 PM

Wells Fargo updates rating for WAVE Life Sciences ( $WVE ) to Overweight, target set at 18 → 16.

0 · Reply

Longbuy1 Nov. 10 at 11:16 PM

$VERA $WVE Vera gonna be rocking again tomorrow

0 · Reply

MysticChartReaderIQ69 Nov. 10 at 6:15 PM

$WVE so raising before full obesity data readout is the problem here ?

1 · Reply

johnnygogogo Nov. 10 at 5:12 PM

$WVE Auntie Em confirmed. $72.1M subsequent to Sept. 30 @skeezbag

0 · Reply

outlawinvestor1 Nov. 10 at 2:21 PM

$WVE just started listening in. did they mention anything about weight loss inhbe data?

0 · Reply

SuperGreenToday Nov. 7 at 6:40 PM

0 · Reply

dirkfrank Nov. 7 at 3:46 PM

$WVE see You in 2030

0 · Reply

Publicola29 Nov. 6 at 10:56 PM

$VKTX $WVE is Viking or better over longer time frame at 1/4 the price. diamond in the rough. Buy WVE!

0 · Reply

biolover Nov. 6 at 6:05 PM

$VKTX $WVE Wve is the most stupid company in all biotech now.

2 · Reply

Publicola29 Nov. 6 at 6:00 PM

$VKTX buy $WVE

0 · Reply

Publicola29 Nov. 5 at 10:09 AM

$ARWR buy $WVE

0 · Reply

dirkfrank Nov. 3 at 3:34 PM

$WVE enormous squeeze

0 · Reply

SqueezeChronometer Nov. 2 at 11:25 AM

Next major retail squeeze candidate right here $WVE $SFL $EW $STRF 2

0 · Reply

SaluteYourShorts Oct. 31 at 3:45 PM

$WVE attagirl

0 · Reply

SaluteYourShorts Oct. 31 at 1:54 PM

$WVE added some at 8.27

0 · Reply

Quantumup Oct. 31 at 1:02 PM

Clear Street y'day (MoC)🏁 $KRRO Buy-$93 $ARWR $TAK $WVE $MREO AZN SNY BEAM VRTX CRSP Clear Street said in its initiation report:

0 · Reply

dirkfrank Oct. 30 at 8:11 PM

$WVE manipulated

0 · Reply

OpenOutcrier Oct. 30 at 1:04 PM

$WVE (+1.7% pre) Wave Life Sciences Announced Positive Target Engagement Data from INLIGHT Clinical Trial of WVE-007 for Obesity During Annual Research Day https://ooc.bz/l/82615

0 · Reply

hichemben Oct. 30 at 7:56 AM

$WVE Looking to breakout, we touched almost $10 but the Fed's cuts PR wiped the entire market gain, which we will continue to push upwards 🚀

0 · Reply

Market Cap	1.18B
Revenue (ttm)	108.30M
Net Income (ttm)	-97.01M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-89.58%
Debt to Equity Ratio	0.00

Volume	2,323,900
Avg Vol	2,696,156
Day's Range	N/A - N/A
Shares Out	167.18M
Stochastic %K	32%
Beta	-1.44
Analysts	Strong Sell
Price Target	$19.80